arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Heartflow, Inc.

HTFL
$28.80 ▲ +1.61 (+5.94%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
11 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Heartflow, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.5B
Dividend Yield
Revenue Growth 41.3%
Op. Margin -56.1%
ROIC -10.3%
FCF / Share $-0.37
Trailing P/E
Price / Book 8.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$52.59M
↑ +41.3%
Net Income Profit after all expenses
$-27.38M
↑ +15.4%
Operating Margin Operating profit as % of sales
-56.1%
↓ -55.3% 7th
FCF / Share Free cash flow per share
$-0.37
↑ +83.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
20
Financial Health
33
Cash Quality
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 11 quarters